• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyrimidines Pyrrolopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyrimidines

Research Brief on 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine (CAS: 1211536-93-4): Recent Advances and Applications

6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine (CAS: 1211536-93-4) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activities, and potential therapeutic applications. The compound's unique structural features make it a valuable scaffold for designing novel inhibitors targeting various enzymes and signaling pathways.

Recent studies have highlighted the role of 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting the JAK-STAT and PI3K-AKT-mTOR pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the development of selective JAK2 inhibitors, which show promise for treating myeloproliferative neoplasms. The bromo and chloro substituents on the pyrrolopyrimidine core enhance its reactivity, enabling further functionalization to optimize pharmacokinetic properties.

In addition to its role in kinase inhibitor development, this compound has been explored as a building block for PROTACs (Proteolysis Targeting Chimeras). A recent preprint on bioRxiv (2024) detailed its incorporation into a novel PROTAC targeting BET proteins, achieving selective degradation of BRD4 in cancer cell lines. The study reported a 70% reduction in BRD4 levels at nanomolar concentrations, underscoring the compound's utility in targeted protein degradation strategies.

The synthetic accessibility of 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine has also been improved through recent methodological advances. A 2023 Organic Process Research & Development paper described a scalable, one-pot synthesis with 85% yield, addressing previous challenges in large-scale production. This development is particularly significant for industrial applications, where consistent supply and cost-effectiveness are critical factors.

Looking forward, the unique properties of 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine position it as a versatile tool in chemical biology. Ongoing research is exploring its applications in fluorescent probes for cellular imaging and as a warhead in covalent inhibitor design. The compound's future potential appears particularly promising in the context of personalized medicine, where its derivatization could yield targeted therapies for specific genetic subtypes of diseases.

• 118721-30-5(5H-Pyrrolo[3,2-d]pyrimidine, 2,7-dibromo-4-chloro-)
• 1379351-33-3(8-Bromo-4-chloropyrido[3,4-d]pyrimidine)
• 1799727-36-8(2-bromo-5-chloro-1H-pyrrolo[3,2-b]pyridine)
• 1032650-41-1(7-Bromo-4-chloro-5H-pyrrolo[3,2-D]pyrimidine)
• 1311275-25-8(6-Bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine)
• 1260665-43-7(6-Bromo-2,4-dichloropyrido[3,2-D]pyrimidine)
• 1824100-34-6(Pyrido[3,2-d]pyrimidine, 6-bromo-4-chloro-)
• 1638767-93-7(6-bromo-4-chloro-1H-imidazo[4,5-c]pyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)